Literature DB >> 2910899

Transient blood-brain barrier permeability following profound temporary global ischaemia: an experimental study using 14C-AIB.

J Dobbin1, H A Crockard, R Ross-Russell.   

Abstract

The influence of reperfusion after profound incomplete forebrain ischaemia on blood-brain barrier (BBB) permeability to a small protein tracer was studied in male Sprague-Dawley rats. The mean cortical blood to brain transfer constant (Ki) for 14C-amino isobutyric acid (AIB) was significantly greater at 3 and 6 h of reperfusion, 2.5 times the mean values of controls (p less than 0.05) (2.5 microliter g-1 min-1 and 1.0 microliters g-1 min-1 respectively), but had returned to control values after reperfusion for 24 h. Analysis of distribution of Ki values showed that following 15 min and 30 min of profound ischaemia, there was a significant increase in transfer of AIB across the blood-brain barrier (BBB) after recirculation for up to 6 h, though there was no evidence of protein extravasation as assessed by Evans Blue (EB) dye. After 24 h of reperfusion, the BBB to AIB was restored, and Ki values had returned to control values. It is concluded that following transient global ischaemia, the BBB may recover rapidly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910899     DOI: 10.1038/jcbfm.1989.10

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  17 in total

1.  Iron mediates endothelial cell damage and blood-brain barrier opening in the hippocampus after transient forebrain ischemia in rats.

Authors:  Sun Mi Won; Jin Hwan Lee; Ui Jin Park; Jina Gwag; Byoung Joo Gwag; Yong Beom Lee
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

Review 2.  Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal.

Authors:  R D Broadwell
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 3.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

4.  Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.

Authors:  K J Becker; R M McCarron; C Ruetzler; O Laban; E Sternberg; K C Flanders; J M Hallenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 5.  Hypothalamic or Extrahypothalamic Modulation and Targeted Temperature Management After Brain Injury.

Authors:  Rishabh Charan Choudhary; Xiaofeng Jia
Journal:  Ther Hypothermia Temp Manag       Date:  2017-05-03       Impact factor: 1.286

6.  Delayed institution of hypertension during focal cerebral ischemia: effect on brain edema.

Authors:  P M Patel; J C Drummond; D J Cole; R Giamela; J Steinauer
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Increased delivery of TAT across an endothelial monolayer following ischemic injury.

Authors:  Melissa J Simon; Woo Hyeun Kang; Shan Gao; Scott Banta; Barclay Morrison
Journal:  Neurosci Lett       Date:  2010-09-17       Impact factor: 3.046

8.  Blood brain barrier is impermeable to solutes and permeable to water after experimental pediatric cardiac arrest.

Authors:  Erika E Tress; Robert S B Clark; Lesley M Foley; Henry Alexander; Robert W Hickey; Tomas Drabek; Patrick M Kochanek; Mioara D Manole
Journal:  Neurosci Lett       Date:  2014-06-14       Impact factor: 3.046

9.  The characteristics of blood-brain barrier in three different conditions--infarction, selective neuronal death and selective loss of presynaptic terminals--following cerebral ischemia.

Authors:  K Kitagawa; M Matsumoto; T Ohtsuki; M Tagaya; T Okabe; R Hata; H Ueda; N Handa; K Sobue; T Kamada
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Region-selective permeability of the blood-brain barrier to α-aminoisobutyric acid during thiamine deficiency and following its reversal.

Authors:  Alan S Hazell; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2020-11-27       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.